Aveanna Healthcare Holdings Inc.

NASDAQ:AVAH

4.61 (USD) • At close April 30, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Revenue 519.872509.023504.958490.653478.841478.01471.945466.413451.147443.009442.955450.534414.07411.276436.112417.16422.302366.003351.577355.223
Cost of Revenue 348.15349.324349.524347.711333.677330.746316.69321.948322.372308.426303.95305.708289.68271.534289.523285.477296.087251.873244.948247.682
Gross Profit 171.722159.699155.434142.942145.164147.264155.255144.465128.775134.583139.005144.826124.39139.742146.589131.683126.215114.13106.629107.541
Gross Profit Ratio 0.330.3140.3080.2910.3030.3080.3290.310.2850.3040.3140.3210.30.340.3360.3160.2990.3120.3030.303
Reseach & Development Expenses 00000000000000000000
General & Administrative Expenses 119.921118.075116.359117.179107.251117.96891.255119.782110.679119.395125.2125.31106.633114.243110.12196.77199.2892.13477.86985.491
Selling & Marketing Expenses 00-0.224-2.6895.019002.86103.3623.524000000000
SG&A 119.921118.075116.135114.49112.27117.96891.255122.643110.679122.757116.319125.31106.633114.243110.12196.77199.2892.13477.86985.491
Other Expenses 6.037.6-0.091-2.32-0.5610.02425.1694.18317.3850-0.0015.6491.1270.0550.0010.159-0.205-0.110.0141.791
Operating Expenses 125.951125.675116.226116.81112.831118.052117.795126.826128.064105.161116.32130.959111.683119.388115.291101.619103.60496.74382.6989.674
Operating Income 45.77134.02439.20826.13232.333-76.35237.49217.639-1.7584.78722.68513.776-113.04818.34730.29428.29617.72612.877-51.95717.867
Operating Income Ratio 0.0880.0670.0780.0530.068-0.160.0790.038-0.0040.0110.0510.031-0.2730.0450.0690.0680.0420.035-0.1480.05
Total Other Income Expenses Net -18.836-61.356-33.147-21.376-60.888-25.406-12.703-48.071-34.68516.842-17.8514.155-9.064-17.357-28.855-22.189-25.057-20.75-23.34120.901
Income Before Tax 26.935-27.3323.9791.49-31.595-101.75824.789-30.432-239.14321.629-474.23127.931-122.1120.991.4396.107-7.331-7.873-75.29838.768
Income Before Tax Ratio 0.052-0.0540.0080.003-0.066-0.2130.053-0.065-0.530.049-1.0710.062-0.2950.0020.0030.015-0.017-0.022-0.2140.109
Income Tax Expense -2.24515.511-9.92712.662-5.8590.631-0.811.566-1.3642.669-0.3442.5974.08-1.10.1790.3092.401-0.4712.2551.131
Net Income 29.18-42.84313.906-11.172-25.736-102.38925.599-31.998-237.77924.298-473.88725.334-126.1922.091.265.798-9.732-7.402-77.55337.637
Net Income Ratio 0.056-0.0840.028-0.023-0.054-0.2140.054-0.069-0.5270.055-1.070.056-0.3050.0050.0030.014-0.023-0.02-0.2210.106
EPS 0.15-0.220.072-0.058-0.13-0.540.14-0.17-1.280.13-2.560.14-0.680.010.010.032-0.068-0.041-0.430.21
EPS Diluted 0.14-0.220.071-0.058-0.13-0.540.13-0.17-1.280.13-2.560.14-0.670.010.010.032-0.068-0.041-0.430.21
EBITDA 72.23519.26151.05935.27715.223-54.88170.20321.75-195.8489.704-441.06560.307-97.8320.06936.46838.69824.58124.692-48.81467.137
EBITDA Ratio 0.1390.0380.1010.0720.032-0.1150.1490.047-0.4340.022-0.9960.134-0.2360.0490.0840.0930.0580.067-0.1390.189